Bsw Wealth Partners Invitae Corp Transaction History

Bsw Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.05 - $1.63 $555 - $862	529 Added 1.52%	35,218 $39,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $17,252 - $39,249	14,377 Added 70.78%	34,689 $46,000
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $1,786 - $3,772	-1,045 Reduced 4.89%	20,312 $37,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $1,784 - $8,103	939 Added 4.6%	21,357 $53,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $21,344 - $90,289	10,021 Added 96.38%	20,418 $50,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $65,293 - $162,089	10,397 New	10,397 $83,000
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $155,827 - $215,376	-6,410 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $167,236 - $258,964	6,410 New	6,410 $216,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Bsw Wealth Partners with notifications on news.